Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock

Retrieved on: 2021-09-16 16:52:30

Tags for this article:

Initial public offering

Financial markets

Finance

Financial economics

Stock market

U.S. Securities and Exchange Commission

SEC filings

Prospectus

Registration statement

Public offering

Forward-looking statement

Form S-1

virpax pharmaceuticals, inc

Click the tags to see associated articles and topics

Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock. View article details on hiswai:

Excerpt

333-259421) was filed with the Securities and Exchange Commission (“SEC”), which became effective on September 14, 2021, relating to the shares of ...

Article found on: www.valdostadailytimes.com

View Original Article